In diabetic cardiomyopathy (DCM), the activity of ADAM17 is increased while the expression of angiotensin-converting enzyme 2 (ACE2), which has beneficial effects in ameliorating left ventricular remodeling and dysfunction, is downregulated. The gene discussed is ACE2; the disease is diabetic cardiomyopathy.